Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)

Summary

A Research Study to evaluate the therapeutic effect of Fespixon cream in patients suffering from DFU (UTWCS Grade III-A or III-B) by measuring the change of grade of UTWCS (University of Texas Diabetic Wound Classification system), wound area reduction, infection control, and incidence of treatment-emergent adverse event (TEAE).

Timeline

Start

2022-08-04

Primary completion

2024-04-03

Completion

2024-04-03

Outcome

Outcome not reported

Stopped: “Study halted prematurely and will not resume.”

Drugs

Indications